A comprehensive epidemiological study analyzing over 255,000 person-years of mortality data has fundamentally challenged the testosterone-centric model that has long dominated male health assessment. Researchers measured five distinct hormonal markers in aging men, revealing that total testosterone, while relevant, was not the strongest predictor of mortality risk in the cohort.
The findings suggest that multiple endocrine pathways work synergistically to influence health outcomes in aging males—a departure from the conventional single-marker approach. This paradigm shift has significant implications for clinical practice, indicating that comprehensive hormone profiling may offer superior prognostic value compared to testosterone measurement alone.
The study underscores the complexity of male aging and endocrine function, advocating for a more nuanced, multidimensional assessment strategy in clinical evaluation and patient management.
Read the full article on GMJ Newsroom.
Was this article helpful?
